205 related articles for article (PubMed ID: 37414783)
21. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
22. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
Liu SL; Liu Z; Zhang LD; Zhu HQ; Guo JH; Zhao M; Wu YL; Liu F; Gao FH
Cell Cycle; 2017; 16(24):2386-2395. PubMed ID: 28980866
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
Masamha CP; Benbrook DM
Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
[TBL] [Abstract][Full Text] [Related]
24. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.
Vaites LP; Lee EK; Lian Z; Barbash O; Roy D; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Mol Cell Biol; 2011 Nov; 31(22):4513-23. PubMed ID: 21911473
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.
Lin DI; Barbash O; Kumar KG; Weber JD; Harper JW; Klein-Szanto AJ; Rustgi A; Fuchs SY; Diehl JA
Mol Cell; 2006 Nov; 24(3):355-66. PubMed ID: 17081987
[TBL] [Abstract][Full Text] [Related]
26. Blocking MG53
Lv F; Wang Y; Shan D; Guo S; Chen G; Jin L; Zheng W; Feng H; Zeng X; Zhang S; Zhang Y; Hu X; Xiao RP
Circ Res; 2022 Dec; 131(12):962-976. PubMed ID: 36337049
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
Wu SY; Lan SH; Wu SR; Chiu YC; Lin XZ; Su IJ; Tsai TF; Yen CJ; Lu TH; Liang FW; Li CY; Su HJ; Su CL; Liu HS
Hepatology; 2018 Jul; 68(1):141-154. PubMed ID: 29328502
[TBL] [Abstract][Full Text] [Related]
28. Suppression of cancer cell growth by promoting cyclin D1 degradation.
Shan J; Zhao W; Gu W
Mol Cell; 2009 Nov; 36(3):469-76. PubMed ID: 19917254
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
32. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.
Barbash O; Diehl JA
Cell Cycle; 2008 Oct; 7(19):2983-6. PubMed ID: 18818515
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
34. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
Hong M; Almutairi MM; Li S; Li J
Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
[TBL] [Abstract][Full Text] [Related]
35. Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells.
Or CR; Chang Y; Lin WC; Lee WC; Su HL; Cheung MW; Huang CP; Ho C; Chang CC
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035994
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1, cancer progression, and opportunities in cancer treatment.
Qie S; Diehl JA
J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879
[TBL] [Abstract][Full Text] [Related]
37. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.
Davis MI; Pragani R; Fox JT; Shen M; Parmar K; Gaudiano EF; Liu L; Tanega C; McGee L; Hall MD; McKnight C; Shinn P; Nelson H; Chattopadhyay D; D'Andrea AD; Auld DS; DeLucas LJ; Li Z; Boxer MB; Simeonov A
J Biol Chem; 2016 Nov; 291(47):24628-24640. PubMed ID: 27681596
[TBL] [Abstract][Full Text] [Related]
38. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
39. Simvastatin induces G
Chen MJ; Cheng AC; Lee MF; Hsu YC
J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
[TBL] [Abstract][Full Text] [Related]
40. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
